Active09431909Private limited companyLeeds

AMO PHARMA LIMITED

Significant control: Dermot Desmond (significant control)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Amo Pharma Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Amo Pharma Limited sell?

Registered activity: Other research and experimental development on natural sciences and engineering (SIC 72190). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

AMO PHARMA LIMITED is an active private limited company (company number 09431909) incorporated on 10 February 2015, registered in Leeds. Its registered activity is other research and experimental development on natural sciences and engineering (SIC 72190). Latest small accounts cover the period ending 31 December 2025, showing net assets of −£49.43m and cash of £349k, with 4 employees on average. Net assets fell 12% on the prior period (−£44.13m).

Peer position · net assets

By net assets it sits in the bottom quarter of 77 comparable companies in Leeds (median £100, upper quartile £63k).

02

Ownership and control

1 active · 2 other
  • Mr Dermot Desmond
    Individual · since 4 February 2020
    • has significant influence or control
  • Woodford Patient Capital Trust Plc
    corporate entity, Uk · since 6 April 2016 · ceased 8 January 2020
    • owns 25–50% of shares
  • Iiu Nominees Limited
    corporate entity, Ireland · since 4 February 2020 · ceased 4 February 2020
    • has significant influence or control

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
10 February 201511 yrs ago
Next accounts due
30 September 2027in 341 days
Confirmation statement due
24 February 2027in 123 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72190
Other research and experimental development on natural sciences and engineering
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 December 2025
Net assets
−£49.43m
vs Dec 2024
Cash at bank
£349k
+124%vs Dec 2024
Turnover
Not reported
Employees
4
No changevs Dec 2024
Net assets
−£49.43m
Cash at bank
£349k
Average employees
4
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2025−£49.43m£349k£1.72m£51.50m——4
31 December 2024−£44.13m£155k£2.54m£46.83m——4
Current ratio0.04Current assets ÷ creditors within one year
Cash per employee£87kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets below zeroNet assets £-49,428,689 at 31 December 2025
  • Current assets below creditors within one yearCurrent ratio 0.04
  • Cash at bank of £50,000 or moreCash £348,940
  • Incorporated five or more years agoIncorporated 10 February 2015

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 341 days
  2. Confirmation statement duein 123 days
  3. Accounts period endNet liabilities £49.43m · small accounts
  4. Accounts period endNet liabilities £44.13m · small accounts
  5. Incorporated
08

Similar companies in Leeds

Same activity (other research and experimental development on natural sciences and engineering), closest in incorporation date
09

Reminders for AMO PHARMA LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.